JP Stock MarketDetailed Quotes

4588 Oncolys BioPharma

Watchlist

674
+20+3.06%

20min DelayMarket Closed Nov 8 15:30 JST

15.38BMarket Cap-6188P/E (Static)

Oncolys BioPharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Total revenue

11.93%31.38M

-93.54%63.04M

-87.97%28.04M

-81.88%35M

51.94%976.18M

-40.87%191.67M

186.11%358.36M

Cost of revenue

-94.91%32.43M

-50.59%32.43M

43.73%637.7M

-44.58%163.34M

201.47%287.66M

Gross profit

11.93%31.38M

-90.96%30.6M

-74.96%28.04M

-97.99%2.57M

70.26%338.49M

-3.70%28.34M

137.01%70.7M

Operating expense

-26.11%445.88M

15.46%378.87M

27.06%1.96B

109.49%618.95M

17.43%410.05M

56.28%603.45M

-35.94%328.15M

-6.68%1.54B

-43.22%295.46M

-2.97%349.18M

Operating profit

27.96%-414.5M

-16.37%-378.87M

-60.23%-1.93B

-131.71%-618.95M

-47.24%-410.05M

-109.89%-575.41M

15.38%-325.58M

17.19%-1.2B

45.59%-267.13M

15.62%-278.48M

Net non-operating interest income (expenses)

-421.40%-2.83M

-337.39%-3.09M

-311.25%-13.93M

-398.88%-4.01M

-862.20%-8.68M

42.46%-542K

4.72%-706K

78.48%-3.39M

46.86%-803K

6.82%-902K

Non-operating interest income

37.76%529K

247.65%518K

151.28%1.48M

262.79%468K

172.41%474K

193.13%384K

-2.61%149K

18.83%587K

15.18%129K

20.83%174K

Non-operating interest expense

12.85%1.05M

33.33%1.14M

-8.69%3.6M

-11.70%823K

-7.25%998K

-13.70%926K

-1.04%855K

-5.37%3.95M

-4.70%932K

-0.55%1.08M

Total other finance cost

--2.31M

--2.47M

39,253.33%11.81M

--3.65M

----

-99.75%30K

--0

Net investment income

-6.30%29.86M

484.84%18.67M

-55.94%27.6M

46.47%-20.08M

-20.12%12.62M

-29.14%31.86M

-91.89%3.19M

67.62%62.64M

-524.70%-37.51M

292.43%15.8M

Gain(Loss) on financial instruments designated as cash flow hedges

Gain(Loss) on derecognition of available-for-sale financial assets

Income from associates and other participating interests

Special income (charges)

-227.99%-21.76M

-397.34%-21.9M

136K

185.68%17M

77.81%-4.4M

Less:Other special charges

----

99.36%-136K

--0

---136K

---21.41M

--0

Less:Write off

----

397.34%21.9M

----

-77.81%4.4M

----

Other non-operating income (expenses)

114.09%2.5M

868.52%2.76M

73.88%-17.76M

92.28%-3.12M

59.53%-359K

Income before tax

28.41%-389.71M

-12.49%-363.29M

-68.90%-1.94B

-112.47%-664.93M

-52.82%-403.34M

-125.98%-544.35M

1.60%-322.96M

28.90%-1.15B

50.70%-312.96M

19.50%-263.94M

Income tax

29.13%931K

27.72%940K

-0.20%2.93M

0.00%733K

-0.27%736K

-0.28%721K

-0.27%736K

-21.29%2.93M

-21.86%733K

-21.74%738K

Net income

28.33%-390.64M

-12.52%-364.23M

-68.72%-1.94B

-112.20%-665.66M

-52.67%-404.08M

-125.60%-545.07M

1.60%-323.69M

28.88%-1.15B

50.66%-313.69M

19.51%-264.68M

Net income continuous operations

28.33%-390.64M

-12.52%-364.23M

-68.72%-1.94B

-112.20%-665.66M

-52.67%-404.08M

-125.60%-545.07M

1.60%-323.69M

28.88%-1.15B

50.66%-313.69M

19.51%-264.68M

Noncontrolling interests

Net income attributable to the company

28.33%-390.64M

-12.52%-364.23M

-68.72%-1.94B

-112.20%-665.66M

-52.67%-404.08M

-125.60%-545.07M

1.60%-323.69M

28.88%-1.15B

50.66%-313.69M

19.51%-264.68M

Preferred stock dividends

Other under preferred stock dividend

Net income attributable to common stockholders

28.33%-390.64M

-12.52%-364.23M

-68.72%-1.94B

-112.20%-665.66M

-52.67%-404.08M

-125.60%-545.07M

1.60%-323.69M

28.88%-1.15B

50.66%-313.69M

19.51%-264.68M

Gross dividend payment

Basic earnings per share

40.51%-18.72

2.41%-18.24

-64.26%-108.92

-97.52%-35.77

-50.46%-22.99

-125.75%-31.47

1.53%-18.69

30.57%-66.31

51.16%-18.11

19.45%-15.28

Diluted earnings per share

40.51%-18.72

2.41%-18.24

-64.26%-108.92

-97.52%-35.77

-50.46%-22.99

-125.75%-31.47

1.53%-18.69

30.57%-66.31

51.16%-18.11

19.48%-15.28

Dividend per share

Currency Unit

JPY

Accounting Standards

NonUS-GAAP

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Total revenue	11.93%31.38M	0	-93.54%63.04M	0	0	-87.97%28.04M	-81.88%35M	51.94%976.18M	-40.87%191.67M	186.11%358.36M
Cost of revenue	0	0	-94.91%32.43M	0	0	0	-50.59%32.43M	43.73%637.7M	-44.58%163.34M	201.47%287.66M
Gross profit	11.93%31.38M	0	-90.96%30.6M	0	0	-74.96%28.04M	-97.99%2.57M	70.26%338.49M	-3.70%28.34M	137.01%70.7M
Operating expense	-26.11%445.88M	15.46%378.87M	27.06%1.96B	109.49%618.95M	17.43%410.05M	56.28%603.45M	-35.94%328.15M	-6.68%1.54B	-43.22%295.46M	-2.97%349.18M
Operating profit	27.96%-414.5M	-16.37%-378.87M	-60.23%-1.93B	-131.71%-618.95M	-47.24%-410.05M	-109.89%-575.41M	15.38%-325.58M	17.19%-1.2B	45.59%-267.13M	15.62%-278.48M
Net non-operating interest income (expenses)	-421.40%-2.83M	-337.39%-3.09M	-311.25%-13.93M	-398.88%-4.01M	-862.20%-8.68M	42.46%-542K	4.72%-706K	78.48%-3.39M	46.86%-803K	6.82%-902K
Non-operating interest income	37.76%529K	247.65%518K	151.28%1.48M	262.79%468K	172.41%474K	193.13%384K	-2.61%149K	18.83%587K	15.18%129K	20.83%174K
Non-operating interest expense	12.85%1.05M	33.33%1.14M	-8.69%3.6M	-11.70%823K	-7.25%998K	-13.70%926K	-1.04%855K	-5.37%3.95M	-4.70%932K	-0.55%1.08M
Total other finance cost	--2.31M	--2.47M	39,253.33%11.81M	--3.65M	----	----	----	-99.75%30K	--0	--0
Net investment income	-6.30%29.86M	484.84%18.67M	-55.94%27.6M	46.47%-20.08M	-20.12%12.62M	-29.14%31.86M	-91.89%3.19M	67.62%62.64M	-524.70%-37.51M	292.43%15.8M
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
Income from associates and other participating interests
Special income (charges)	0	0	-227.99%-21.76M	-397.34%-21.9M	0	0	136K	185.68%17M	77.81%-4.4M	0
Less:Other special charges	----	----	99.36%-136K	--0	--0	--0	---136K	---21.41M	--0	--0
Less:Write off	----	----	397.34%21.9M	----	----	----	----	-77.81%4.4M	----	----
Other non-operating income (expenses)			114.09%2.5M	0	868.52%2.76M			73.88%-17.76M	92.28%-3.12M	59.53%-359K
Income before tax	28.41%-389.71M	-12.49%-363.29M	-68.90%-1.94B	-112.47%-664.93M	-52.82%-403.34M	-125.98%-544.35M	1.60%-322.96M	28.90%-1.15B	50.70%-312.96M	19.50%-263.94M
Income tax	29.13%931K	27.72%940K	-0.20%2.93M	0.00%733K	-0.27%736K	-0.28%721K	-0.27%736K	-21.29%2.93M	-21.86%733K	-21.74%738K
Net income	28.33%-390.64M	-12.52%-364.23M	-68.72%-1.94B	-112.20%-665.66M	-52.67%-404.08M	-125.60%-545.07M	1.60%-323.69M	28.88%-1.15B	50.66%-313.69M	19.51%-264.68M
Net income continuous operations	28.33%-390.64M	-12.52%-364.23M	-68.72%-1.94B	-112.20%-665.66M	-52.67%-404.08M	-125.60%-545.07M	1.60%-323.69M	28.88%-1.15B	50.66%-313.69M	19.51%-264.68M
Noncontrolling interests
Net income attributable to the company	28.33%-390.64M	-12.52%-364.23M	-68.72%-1.94B	-112.20%-665.66M	-52.67%-404.08M	-125.60%-545.07M	1.60%-323.69M	28.88%-1.15B	50.66%-313.69M	19.51%-264.68M
Preferred stock dividends
Other under preferred stock dividend	0	0	0	0	0	0	0	0	0	0
Net income attributable to common stockholders	28.33%-390.64M	-12.52%-364.23M	-68.72%-1.94B	-112.20%-665.66M	-52.67%-404.08M	-125.60%-545.07M	1.60%-323.69M	28.88%-1.15B	50.66%-313.69M	19.51%-264.68M
Gross dividend payment
Basic earnings per share	40.51%-18.72	2.41%-18.24	-64.26%-108.92	-97.52%-35.77	-50.46%-22.99	-125.75%-31.47	1.53%-18.69	30.57%-66.31	51.16%-18.11	19.45%-15.28
Diluted earnings per share	40.51%-18.72	2.41%-18.24	-64.26%-108.92	-97.52%-35.77	-50.46%-22.99	-125.75%-31.47	1.53%-18.69	30.57%-66.31	51.16%-18.11	19.48%-15.28
Dividend per share
Currency Unit	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY
Accounting Standards	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data